Natixis Advisors LLC Buys 40,860 Shares of Agilent Technologies, Inc. $A

Natixis Advisors LLC increased its stake in Agilent Technologies, Inc. (NYSE:A) by 32.7% in the 4th quarter, HoldingsChannel.com reports. The fund owned 165,710 shares of the medical research company’s stock after purchasing an additional 40,860 shares during the quarter. Natixis Advisors LLC’s holdings in Agilent Technologies were worth $22,548,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the stock. Massachusetts Financial Services Co. MA increased its stake in shares of Agilent Technologies by 13.8% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock valued at $1,925,064,000 after acquiring an additional 1,713,216 shares in the last quarter. Wellington Management Group LLP increased its stake in Agilent Technologies by 4.8% during the 3rd quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock valued at $1,203,990,000 after purchasing an additional 433,342 shares in the last quarter. Geode Capital Management LLC increased its stake in Agilent Technologies by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock valued at $1,006,519,000 after purchasing an additional 25,139 shares in the last quarter. Generation Investment Management LLP increased its stake in Agilent Technologies by 10.1% during the 3rd quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock valued at $816,043,000 after purchasing an additional 582,093 shares in the last quarter. Finally, Norges Bank bought a new stake in Agilent Technologies during the 4th quarter valued at $549,158,000.

Agilent Technologies Price Performance

A opened at $135.51 on Friday. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The company has a market capitalization of $38.27 billion, a price-to-earnings ratio of 27.21, a P/E/G ratio of 2.46 and a beta of 1.26. The firm’s fifty day moving average price is $118.35 and its two-hundred day moving average price is $128.35. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.27.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. The firm had revenue of $1.84 billion for the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, analysts anticipate that Agilent Technologies, Inc. will post 5.99 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be issued a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 30th. Agilent Technologies’s payout ratio is currently 20.48%.

Analyst Ratings Changes

A has been the subject of a number of recent research reports. Bank of America upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and decreased their price target for the company from $150.00 to $145.00 in a research note on Thursday, May 28th. Weiss Ratings upgraded shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. UBS Group decreased their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Finally, HSBC decreased their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Wednesday. One analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $161.71.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.